Table 2 Detectability.
From: Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration
Tear fluid biomarker detectability n (%) | HC (n = 9) | SCD (n = 23) | MCI (n = 22) | Dem (n = 11) | Total study group (n = 65) |
|---|---|---|---|---|---|
Tear AB38 | 2 (22%) | 3 (13%) | 5 (22%) | 2 (18%) | 12 (18%) |
Tear AB40 | 9 (100%) | 23 (100%) | 20 (87%) | 11 (100%) | 63 (97%) |
Tear AB42 | 7 (78%) | 2 (9%) | 4 (17%) | 2 (18%) | 15 (23%) |
Tear t-tau | 9 (100%) | 19 (83%) | 22 (100%) | 11 (100%) | 61 (94%) |
Tear p-tau | 0 (0%) | 4 (17%) | 5 (22%) | 3 (27%) | 12 (18%) |
